Table 3. Comparison of clinical and pathologic factors between patients with high, low, and average metabolic parenchyma.
| Characteristic | High metabolic parenchyma (n = 22) | Low metabolic parenchyma (n = 29) | Average metabolic parenchyma (n = 247) | p-value* | p-value† |
|---|---|---|---|---|---|
| Age (yr) | 40 ± 8 | 44 ± 5 | 43 ± 6 | 0.043 | 0.064 |
| Height (cm) | 160.14 ± 6.10 | 159.48 ± 5.24 | 159.32 ± 4.99 | 0.683 | 0.767 |
| Weight (kg) | 58.87 ± 8.24 | 60.64 ± 9.00 | 57.95 ± 8.68 | 0.472 | 0.273 |
| BMI (kg/m2) | 23.06 ± 3.83 | 23.81 ± 3.05 | 22.84 ± 3.17 | 0.439 | 0.305 |
| Histologic grade | 0.973 | 0.865 | |||
| Low | 13 (7.1) | 17 (9.3) | 152 (83.5) | ||
| High | 9 (8.2) | 12 (10.9) | 89 (80.9) | ||
| Nuclear grade | 0.903 | 0.458 | |||
| Low | 11 (6.6) | 14 (8.4) | 141 (84.9) | ||
| High | 11 (8.7) | 15 (11.9) | 100 (79.4) | ||
| Estrogen receptor | 0.286 | 0.416 | |||
| Positive | 15 (6.6) | 25 (11.0) | 187 (82.4) | ||
| Negative | 6 (9.0) | 4 (6.0) | 57 (85.1) | ||
| Progesterone receptor | 0.574 | 0.844 | |||
| Positive | 16 (7.6) | 20 (9.5) | 174 (82.9) | ||
| Negative | 5 (6.0) | 9 (10.7) | 70 (83.3) | ||
| HER2 | 0.320 | 0.247 | |||
| Positive | 6 (12.2) | 5 (10.2) | 38 (77.6) | ||
| Negative | 14 (5.7) | 24 (9.8) | 206 (84.4) | ||
| Menstrual cycle | 0.002 | 0.001 | |||
| 1st week | 8 (10.0) | 4 (5.0) | 68 (85.0) | ||
| 2nd week | 9 (14.5) | 5 (8.1) | 48 (77.4) | ||
| 3rd week | 3 (4.3) | 3 (4.3) | 64 (91.4) | ||
| 4th week | 2 (2.3) | 17 (19.8) | 67 (77.9) |
Data are presented as mean±SD or number (%).
BMI=body mass index; HER2=human epidermal growth factor receptor 2.
*Between patients with high and low metabolic parenchyma; †Between patients with high, low, and average metabolic parenchyma.